What is CVE-2023-51141?

CVE-2023-51141 is a medium-severity vulnerability in Zkteco Biotime, classified under Authorization Bypass Through User-Controlled Key. CVSS score: 6.5/10. Published 2024-04-11.

How severe is CVE-2023-51141?

Medium severity. CVSS v3 base score is 6.5 out of 10.

Is CVE-2023-51141 known to be exploited?

1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.

Auth bypass in Zkteco Biotime

CVE-2023-51141

An issue in ZKTeko BioTime v.8.5.4 and before allows a remote attacker to obtain sensitive information via the Authentication & Authorization component

Vulnerability class: IDOR (Insecure Direct Object Reference)

EPSS: 0.008 (53.4th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 6.5 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N.

Affected products

Zkteco Biotime — versions 8.5.4
N/a — versions n/a

Weakness classification (CWE)

CWE-639 — Authorization Bypass Through User-Controlled Key

Public proof-of-concept exploits

NaInSec/CVE-LIST

References

cve@mitre.org (Broken Link)
cve@mitre.org (Permissions Required)
cve@mitre.org (Exploit, Third Party Advisory)

Frequently asked questions

What is CVE-2023-51141?: CVE-2023-51141 is a medium-severity vulnerability in Zkteco Biotime, classified under Authorization Bypass Through User-Controlled Key. CVSS score: 6.5/10. Published 2024-04-11.
How severe is CVE-2023-51141?: Medium severity. CVSS v3 base score is 6.5 out of 10.
Is CVE-2023-51141 known to be exploited?: 1 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.